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Two cerimetric procedures are described for the assay of oxcarbazepine (OXC) in bulk drug and in tablets. Titrimetry
(method A) is based on the reaction of OXC by a measured excess cerium(IV) sulphate in sulphuric acid medium and
the determination of the unreacted oxidant by titration with iron(II) solution using ferroin as indicator.
Spectrophotometry (method B) is based on oxidation of OXC by cerium(IV) in perchloric acid (HClO4) medium and the
determination of the unreacted oxidant using a colour reaction with p-dimethylaminobenzaldehyde (p-DMAB) having
an absorption maximum of 460 nm. The titrimetric method is applicable in the range of 2.0–20.0 mg OXC with a 1:2 re-
action stoichiometry [OXC:Ce(IV)]. In the spectrophotometric method a rectilinear relationship is obtained over the
concentration range of 0.3–6.0 μg mL–1 OXC. The linear regression equation of the calibration graph is A =
0.9820–0.1477 C with a regression coefficient (r) of –0.9967 (n = 6). The molar absorptivity is calculated to be 3.76 ×
104 L mol–1 cm–1 and the Sandell sensitivity is 0.0067 μg cm–2. The limits of detection (LOD) and quantification (LOQ)
values are calculated according to ICH guidelines. The methods are successfully applied to the determination of OXC in
tablets.
Keywords: oxcarbazepine; assay; titrimetry; spectrophotometry; tablets
1. Introduction
Oxcarbazepine (OXC), (chemically known as
10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carbox-
amide, (Figure 1) is an antiepileptic agent which belongs
to the iminostilbene class and is effective against partial
seizures and generalized tonic–clonic seizures1 as well as
bipolar affective disorders.2
OXC is not official in any Pharmacopoeia. High per-
formance liquid chromatography,3–6 high performance
thin layer chromatography,7 gas chromatography,6 mi-
croemulsion electrokinetic chromatography,8 capillary
electrokinetic chromatography,9 voltammetry,10,11 capil-
lary electrophoresis12 and visible spectrophotometry13–15
were found in the literature for the assay of OXC in phar-
maceuticals.
No titrimetric method is reported for OXC.
However, few spectrophotometric methods are found.
Gandhimathi and Ravi13 have reported two spectrophoto-
metric methods for the determination of OXC. The first
method involves addition of Folin-Ciocalteu’s (F-C)
reagent to OXC in alkaline medium, followed by meas-
urement of absorbance at 760 nm, and the second method
involves addition of a fixed volume of 3-methyl-2-ben-
zothiazolinone hydrazine hydrochloride (MBTH) after
treatment of OXC with iron(III) chloride and measure-
ment of the absorbance at 456 nm. In another report,14
OXC has been determined using iron(III) chloride and
potassium hexacyanoferrate(III). The method is based on
reduction of iron(III) ions to iron(II) ions by the drug,Figure 1. Chemical structure of OXC
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which in the presence of hexacyanoferrate(III) produces
green-coloured chromogen measured at 770 nm. The yel-
low chromogen with an absorption maximum at 430 nm
formed by the reaction of OXC with methanolic KOH in
DMSO medium as the basis for the assay of OXC has
been reported by Sathish and Nagendrappa.15 All the re-
ported methods have one or more disadvantages (Table 1)
such as low sensitivity,13–15 use of a toxic solvent (to dis-
solve OXC)13 or preparation of reagents15 and require
heating on a boiling water bath.14
The present paper describes a titrimetric (method A)
and a spectrophotometric (method B) procedure for the
assay of OXC in the pure drug and in tablets using ceri-
um(IV) as an oxidimetric reagent.
2. Experimental
2. 1. Apparatus
A Systronics model 106 digital spectrophotometer
(Systronics Limited, Ahmedabad, India) with 1 cm path
length and matched quartz cells was used to record the ab-
sorbance values. An Acculab (Sartorious Group, Ger-
many) electronic analytical balance was used for weigh-
ing.
2. 2. Reagents and Standards
All chemicals used were of analytical reagent grade.
Distilled water was used throughout the investigation.
Acetic acid (7 mol L–1), sulphuric acid (H2SO4) (10
mol L–1) and perchloric acid (HClO4) (4 mol L
–1) were pre-
pared by diluting appropriate volumes of their concentrated
acids (99% glacial acetic acid, 98% H2SO4, 70% HClO4 -all
from Merck, Mumbai, India) with distilled water, and 10
mol L–1 H2SO4 was diluted further to obtain 0.5 mol L
–1 and
used in the preparation of the cerium(IV) solution. Two
brands of tablets, viz. Trioptal-300 (Novartis India Ltd,
Mumbai, India) and Oxetol-600 (Sun Pharmaceuticals,
Sikkim) were purchased from local commercial sources.
2. 2. 1. Cerium(IV) Sulphate Solution 
(0.025 mol L–1)
A 0.025 mol L–1 solution was prepared by dissolv-
ing an accurately weighed quantity of ceric sulphate
[Ce(SO4)2.4H2O; assay 99%-from Loba Chemie Ltd,
Mumbai, India] in 0.5 mol L–1 H2SO4 with the aid of heat.
The solution was cooled to room temperature, and filtered
using Whatman No. 42 filter paper. The solution was used
for the assay in method A after standardization.21 This so-
lution, equivalent to ∼3504 μg mL–1 Ce4+, was diluted
with 4 mol L–1 HClO4 to get a working concentration of
300 μg mL–1 Ce4+.
2. 2. 2. Ferrous Ammonium Sulphate [Fe(II)]
Solution (0.025 mol L–1)
An accurately weighed amount of 9.804 g of
[NH4]2[Fe][SO4]2·6H2O (Loba Chemie Ltd, Mumbai,
India) was dissolved in 10 mL of 0.5 mol L–1 H2SO4 in a
1000-mL volumetric flask and the solution was brought
up to the mark with water.
2. 2. 3. p-Dimethylaminobenzaldehyde 
(p-DMAB) (0.5%)
An accurately weighed amount of 1.25 g of p-
DMAB (Merck, Mumbai, India) was transferred to a 250-
mL volumetric flask, dissolved in 4 mol L–1 HClO4 and
the volume made up to the mark with the same solvent.
Table 1: Comparison of performance characteristics of the proposed spectrophotometric method with reported spectrophotometric methods.
Sl Reagent(s) Method λ Linear range Remarks Reference
No (nm) (μg mL–1)
ε/LOD/LOQ*
1 a) F-C reagent Blue 760 5–30 Narrow linear dynamic  13
chromogen 8.06 × 103/1.6/5.0 range, less sensitive, 
measured methanol used as solvent
b) MBTH-iron(III) Orange coloured 456 10–50 Narrow linear dynamic range,
chloride product measured 3.13 × 103/3/10 less sensitive
2 Iron(III) chloride- Green chromogen 770 4–28 Narrow linear dynamic range, 14
hexacyanoferrate(III) measured 4.63× 103 less sensitive, heating required
3 CH3OH- Yellow chromogen 430 1.0–7.02 Methanol used, less sensitive 15
KOH/DMSO measured 1.21× 104/0.027/0.082
4 Cerium(IV)- Orange chromogen 460 0.3–6.0 Wide linear dynamic range, Present 
p-DMAB/HClO4 measured 3.76× 10
4/0.1/0.32 highly sensitive, no use of work
organic solvent, no heatingrequired
* ε in L mol–1 cm–1; LOD and LOQ are in μg mL–1
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2. 2. 4. Stock OXC Solution
A stock standard solution containing 2 mg mL–1
OXC was prepared by dissolving 200 mg of pure OXC
(Jubilant Life Sciences Ltd, Nanjangud, Mysore, India,
purity 99.5%) in 40 mL of glacial acetic acid; the volume
was brought to 100 mL with water in a volumetric flask
and used for the assay in method A.
A 100 μg mL–1 OXC standard solution was also pre-
pared by dissolving an accurately weighed amount of 10
mg of pure OXC with 4 mol L–1 HClO4 in a 100-mL cali-
brated flask. A working solution with a concentration of
10 μg mL–1 OXC was used in method B.
2. 3. General Procedure
2. 3. 1. Titrimetry (Method A)
A 1–10 mL aliquot of pure drug solution (2 mg
mL–1) containing 2.0–20.0 mg of OXC was measured ac-
curately and transferred to a 100-mL titration flask; the
total volume was brought to 10 mL with 7 mol L–1 acetic
acid. The solution was acidified by adding 5 mL of 10
mol L–1 H2SO4. Ten mL of 0.025 mol L
–1 Ce(IV) stan-
dard solution was added by means of a micro burette and
the content was mixed well. After 5 min, the unreacted
Ce(IV) was back titrated with 0.025 mol L–1 Fe(II) solu-
tion using ferroin as an indicator. A blank titration was
also performed in a similar fashion but in the absence of
the drug.
The amount of the drug present in the measured
aliquot was calculated by using the formula:
where V is the volume of Ce(IV) reacted, M is the molar
concentration (mol L–1) of Ce(IV), Mw is the relative mo-
lecular mass of OXC and n is the number of moles of
Ce(IV) reacting with each mole of OXC.
2. 3. 2. Spectrophotometry (Method B)
Different aliquots (0.3–6.0 mL) of 10 μg mL–1 OXC
standard solution were transferred to 10-mL volumetric
flasks using a microburette and the total volume in each
flask was adjusted to 6 mL by adding 4 mol L–1 HClO4.
To each flask, 1 mL of 300 μg mL–1 Ce4+ solution was
added, and the content was mixed well and kept aside for
15 min at room temperature. Finally, 1 mL of 0.5% p-
DMAB was added to each flask and the volume was
made up to mark with 4 mol L-1 HClO4. After 15 min, the
absorbance of the coloured product was measured at 460
nm against water.
A calibration graph was prepared by plotting ab-
sorbance against concentration and the unknown concen-
tration was read from the graph or computed from the re-
gression equation.
2. 4. Procedure for the Analysis of Tablets
Method A
Twenty tablets were weighed and finely powdered.
The tablet powder equivalent to 200 mg OXC was trans-
ferred to a 100-mL volumetric flask, and about 40 mL of
glacial acetic acid was added. The content of the flask was
shaken for 10 min, 30 mL of water was added, and shak-
ing continued for 10 more min before the flask was filled
to the mark with water. The content was mixed well and
filtered through a Whatman No. 42 filter paper. The first
10-mL portion of the filtrate was discarded and a suitable
aliquot (say 5 mL) was then subjected to analysis by fol-
lowing the procedure described earlier.
Method B
A quantity of tablet powder containing 10 mg of
OXC was transferred into a 100-mL volumetric flask. The
content was shaken well with about 70 mL of 4 mol L–1
HClO4 for 20 min. The mixture was diluted to the mark
with the same solvent and filtered using Whatman No 42
filter paper. The first 10-mL portion of the filtrate was dis-
carded and the resulting tablet extract (100 μg mL–1 in
OXC) was diluted to 10 μg mL–1 with 4 mol L–1 HClO4. A
suitable aliquot was then subjected to analysis by follow-
ing the general procedure.
2. 5. Procedure for the Analysis of Placebo
Blank and Synthetic Mixture
A placebo blank containing starch (10 mg), acacia
(15 mg), hydroxyl cellulose (10 mg), sodium citrate (10
mg), talc (20 mg), magnesium stearate (15 mg) and sodium
alginate (10 mg) was prepared by combining all compo-
nents to form a homogeneous mixture. An amount of 5 mg
of the placebo blank was accurately weighed and its solu-
tion was prepared as described under štablets’, and then
subjected to analysis by following the general procedure.
A synthetic mixture was prepared by adding an ac-
curately weighed amount of 200 mg of OXC to the place-
bo mentioned above. The extraction procedure for tablets
as described for method A and method B were applied
separately by taking the required quantity of synthetic
mixture to prepare 2 mg mL–1 and 10 μg mL–1 OXC solu-
tions, respectively. Three different volumes of the result-
ing synthetic mixture solution (equivalent to 5, 10 and 15
mg OXC in method A; 2, 3 and 4 μg mL–1 in method B)
were subjected to analysis by following the respective
procedure.
3. Results and Discussions
The proposed methods are indirect and are based on
the determination of unreacted cerium(IV) after the reac-
tion between OXC and the oxidant is complete according
to the following reactions:
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The titrimetric method (method A) involves oxida-
tion of OXC by a known excess of Ce(IV) sulphate in sul-
phuric acid medium and the unreacted oxidant was deter-
mined by back titrating with FAS. The reaction between
OXC and Ce(IV) was found to occur in an 1:2 (drug:oxi-
dant) stoichiometric ratio and all calculations are based on
this fact. Using 0.025 mol L–1 Ce(IV), 2–20 mg of OXC
was conveniently determined. In spectrophotometry
(method B), the unreacted Ce4+ was treated with p-DMAB
in HClO4 medium to yield formic acid and p-dimethy-
laminophenol, which upon further oxidation gave the cor-
responding quinoimine derivative.22
4. Method Development
4. 1. Absorption Spectra (method B)
The addition of p-DMAB to Ce4+ resulted in the for-
mation of orange coloured product (quinoimine deriva-
tive) that was measured at 460 nm. OXC and p-DMAB
had no absorption at 460 nm. The decrease in the absorp-
tion intensity at 460 nm, caused by the presence of the
drug, was directly proportional to the amount of drug re-
acted. Figure 2 illustrates the absorption spectra of the or-
ange coloured product formed by the reaction between
Ce4+ and p-DMAB for various OXC concentrations.
4. 2. Optimization of Reaction Variables
Method A
OXC is not soluble in any of the acids other than
acetic acid. To prepare OXC stock solution, different
volume ratios of acetic acid and water were tried, and the
drug was found to be completely soluble in 7 mol L–1
acetic acid and OXC was found to be stable for more
than a day at room temperature. This approach was fol-
lowed to prepare the OXC solution throughout the inves-
tigation.
In order to obtain the optimum conditions necessary
for the quantitative determination of OXC, a fixed amount
of the drug was titrated under varying experimental condi-
tions. The reaction was found to be quantitative and stoi-
chiometric in H2SO4 medium. A constant reaction stoi-
chiometry of 1:2 [OXC:Ce(IV)] was obtained when
4.0–6.0 mL of 10 mol L–1 H2SO4 was used in a total vol-
ume of 25 mL. Hence, a 5 mL of 10 mol L–1 H2SO4 was
used as the optimum for the reaction between OXC and
Ce(IV), giving an overall acidity of 2 mol L–1 with respect
to H2SO4, and for the latter’s titration with iron(II). The
reaction time was studied by titrating the unreacted
Ce(IV) with iron(II) at different time intervals after addi-
tion of oxidant to the acidic solution of OXC. It was found
that the reaction yielded a constant stoichiometry in the
time range from 5 to 10 min, and at a reaction time less
than 5 min and more than 10 min, there was no constant
and definite reaction stoichiometry. Hence, it is necessary
to terminate the reaction at the end of the fifth min by
titrating residual Ce(IV) with iron(II).
Method B
Selection of Reaction Medium
Perchloric acid (4 mol L–1) medium was found nec-
essary for rapid and quantitative reaction between OXC
and Ce(IV), and to obtain maximum and constant ab-
sorbance values of the Ce4+-p-DMAB reaction product at
460 nm. This may be attributed to the highest oxidation
potential of Ce4+ in HClO4 (Eo = 1.75 V) as compared to
that of Ce(IV) in H2SO4 (Eo = 1.44 V), HNO3 (Eo = 1.61
V) or HCl (Eo = 1.28 V)
23. Therefore, all the solutions
[OXC, Ce(IV) and p-DMAB] were prepared in 4 mol L–1
Figure 2. Absorption spectra of coloured product formed by the re-
action between Ce4+ and p-DMAB in the presence of increasing
concentrations of OXC and in the absence of OXC.
625Acta Chim. Slov. 2011, 58, 621–628
Rajendraprasad et al.:  Volumetric and Spectrophotometric Determination of Oxcarbazepine in Tablets
HClO4 throughout the investigation and the same was
maintained as reaction medium.
Optimization of Ce4+
To fix the optimum concentration of Ce4+, different
concentrations of oxidant were reacted with a fixed con-
centration of p-DMAB in HClO4 medium and the ab-
sorbance measured at 460 nm. A constant and maximum
absorbance resulted with 30 μg mL–1 Ce4+; hence, differ-
ent concentrations of OXC were treated with 1 mL of 300
μg mL–1 Ce4+ in HClO4 medium before determining the
residual Ce4+ by reacting with p-DMAB. This facilitated
the optimization of the linear dynamic range over which
the procedure could be applied for the assay of OXC.
Study of Reaction Time and Stability of the Coloured
Species
Under the described experimental conditions, the re-
action between OXC and Ce4+ was complete within 15
min (Figure 3) at room temperature (28 ± 2 °C). After the
addition of p-DMAB, a reaction time of 15 min was nec-
essary for the formation of the coloured product, and
thereafter, the absorbance of the coloured product
(quinoimine derivative) was stable for more than one
hour.
Effect of Diluent
In order to select the proper diluent different solvent
were tried. The highest absorbance values were obtained
when 4 mol L–1 HClO4 was used as diluent. Substitution
of 4 mol L–1 HClO4 with other solvent (methanol, water
and 6 mol L–1 HClO4) resulted in a decrease in the ab-
sorbance values.
4. 3. Method Validation
4. 3. 1. Linearity and Sensitivity
Over the range investigated (2–20 mg), a fixed stoi-
chiometry of 1:2 [OXC : Ce(IV)] was obtained in titrime-
try which served as the basis for calculations. A rectilinear
calibration graph was obtained for the range 0.3–6.0 μg
mL–1 OXC; the measured absorbance values were plotted
versus concentration. The least square calibration equa-
tion was A = 0.9820–0.1477 C (where the concentration C
is measured in μg mL–1) with a regression coefficient of
–0.9967 (n = 6). The calculated molar absorptivity and
Sandell sensitivity values are 3.76 × 104 L mol–1 cm–1 and
0.0067 μg cm–2, respectively. The limits of detection
(LOD) and quantification (LOQ) were calculated accord-
ing to the ICH guidelines24 using the formulae: LOD = 3.3
S/slope and LOQ = 10 S/slope, where S is the standard de-
viation of the absorbance of six blank readings. The calcu-
lated LOD and LOQ are 0.10 and 0.32 μg mL–1, respec-
tively.
4. 3. 2. Accuracy and Precision
The repeatability of the proposed methods was de-
termined by performing replicate determinations. The in-
tra-day and inter-day variations in the analysis of OXC
were measured at three different levels by calculating per-
centage relative standard deviations (%RSD). Accuracy
was evaluated as the bias (percentage relative error be-
tween the measured and reference value). The results of
this study are compiled in Table 2 and show an excellent
Figure 3. Effect of time on the reaction between Ce4+ and OXC
(5.0 μg mL–1)
Table 2: Intra-day and inter-day accuracy and precision.
Method* OXC, Intra-day accuracy and precision Inter-day accuracy and precision
Reference OXC found RE % RSD % OXC found RE % RSD %
A 6.0 5.90 1.67 1.56 5.92 1.33 2.11
12.0 11.85 1.25 1.11 11.80 1.67 1.89
18.0 17.50 2.78 1.85 17.42 3.22 1.56
B 2.0 2.04 2.00 3.10 2.05 2.50 3.26
4.0 4.04 1.00 1.13 4.08 2.00 1.56
6.0 5.83 2.83 0.50 5.90 1.67 2.13
* In method A, OXC reference/found values are in mg and they are μg mL–1 in method B
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intermediate precision (%RSD ≤ 3.26) and accuracy
(%RE ≤ 3.22).
4. 3. 3. Selectivity
In the analysis of the placebo blank there was no
measurable consumption of Ce(IV) (method A) and the
same absorbance value as obtained for the reagent blank
was recorded in method B, suggesting that the inactive in-
gredients added to prepare the placebo are interference-
free.
In method A, 5 mL of the resulting solution prepared
using the synthetic mixture was assayed titrimetrically (n
= 3) yielded a recovery of 102.3 ± 0.62% OXC. In method
B, a 3 mL aliquot of 10 μg mL–1 OXC subjected to analy-
sis (n = 5) yielded a recovery of 101.7 ± 0.86% OXC.
These results complement the findings of the placebo
blank analysis with respect to selectivity.
4. 3. 4. Robustness and Ruggedness
To evaluate the robustness of the methods, reaction
time and H2SO4 concentrations were slightly altered with
reference to optimum values in titrimetry. However, in
spectrophotometry, the reaction time and volume of p-
DMAB were altered. To check the ruggedness, analysis
was performed by four different analysts and using three
different burettes (method A) or cuvettes (method B) by
the same analyst. The robustness and the ruggedness were
checked at three different drug levels. The intermediate
precision, expressed as percent RSD, is a measure of the
robustness and ruggedness and was within acceptable lim-
its (0.72–3.74%, Table 3).
4. 3. 5. Application to Tablet Analysis
Commercial OXC tablets were analyzed by the de-
veloped methods and also by a reference published
method.13 The published method involves addition of
Folin-Ciocalteu’s (F-C) reagent to OXC in alkaline medi-
um, followed by measurement of the absorbance at 760
nm. The results obtained were compared statistically by
the Student’s t-test and the variance-ratio F-test.25 The cal-
culated t- and F- values did not exceed the tabulated val-
ues [2.77 (t) and 6.39 (F) at the 95 % confidence level and
for four degrees of freedom], indicating a close similarity
between the proposed methods and the reference method
with respect to accuracy and precision (see Table 4 for a
summary).
4. 3. 6. Recovery Study
To further ascertain the accuracy and reliability of
the methods, recovery experiments were performed via
the method of standard additions. Pre-analyzed tablet
powder was spiked with pure OXC at three different levels
Table 3: Robustness and ruggedness.
Method A Method B
Robustness Ruggedness Robustness Ruggedness
(RSD %) (RSD %) (RSD %) (RSD %)
OXC Conditions altered* OXC Conditions altered*
studied Volume Reaction Inter- Inter- studied Volume of Reaction Inter- Inter-
mg of H2SO4 time analysts burettes μg mL
–1 p-DMAB time analysts instruments
(n = 3) (n=3) (n = 4) (n = 4) (n = 3) (n = 3) (n = 4) (n = 3)
6.0 1.56 2.26 1.65 2.01 2.0 1.58 2.67 1.56 3.74
12.0 1.38 1.84 0.72 1.85 4.0 2.11 1.54 2.38 1.94
18.0 1.74 1.47 1.41 1.56 6.0 1.99 3.14 1.85 2.48
* In method A, volumes of 10 mol L–1 H2SO4 varied were 5 ± 1 mL, and reaction times were 5 ± 0.5 min, In method B, volumes of p-DMAB var-
ied were 1 ± 0.1 mL, and reaction times employed were 15 ± 1 min.
Table 4: Results of analysis of tablets by the proposed methods.
Tablets Label claim, Found* (Percent label claim ±SD)
analysed mg/tablet Reference method Method A Method B
Trioptal 300 300 100.3 ± 1.22 98.5 ± 0.89 99.6 ± 1.28
t = 2.69 t = 0.88
F = 1.88 F = 1.10
Oxetol 600 600 99.58 ± 0.85 100.6 ± 1.10 101.2±1.56
t = 1.65 t = 2.12
F = 1.67 F = 3.37
* Mean value of five determinations.
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and the total was found by the proposed methods. Each
determination was repeated three times. The percent re-
covery of pure OXC added (Table 5) was within the per-
missible limits indicating the absence of inactive ingredi-
ents in the assay.
5. Conclusion
A titrimetric and a spectrophotometric method was
developed and validated for the determination of oxcar-
bazepine using cerium(IV) sulphate as the oxidimetric
reagent. The methods have been demonstrated to be sim-
ple, rapid, economical and accurate and precise; they were
successfully applied to the determination of OXC in
tablets. Especially titrimetry is a simpler and faster tech-
nique for determination of oxcarbazepine than all other
methods reported so far. It is applicable over a wide range
(2–20 mg), requires inexpensive chemicals, and yet pro-
vides very accurate and precise results. The proposed
spectrophotometric method has the advantages of high
sensitivity, which permits the determination of a concen-
tration of oxcarbazepine even down to 0.32 μg mL–1 with
fair accuracy and precision. Compared to many existing
instrumental methods for oxcarbazepine, the proposed
spectrophotometric method has two additional advan-
tages, viz. simplicity of operation and the use of generic
laboratory instruments. Since the method requires easily
available reagents [Ce(IV) and p-DMAB], it is certainly
the most cost-effective of all the existing spectrophoto-
metric methods.
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Povzetek
Opisana sta cerimetri~na postopka za dolo~evanje okskarbazepina (OXC) v farmacevtskih preparatih. Titrimetri~na
metoda (metoda A) temelji na reakciji OXC s prese`kom cerijevega (IV) sulfata v `veplenokislem mediju in dolo~itvi-
jo nezreagiranega oksidanta s titracijo z raztopino Fe(II) z uporabo feroina kot indikatorja. Spektrofotometri~na
dolo~itev (metoda B) temelji na oksidaciji OXC s Ce(IV) v perkloratnem (HClO4) mediju in dolo~itvijo nezreagiranega
oksidanta z barvno reakcijo s p-dimetilaminobenzaldehidom (p-MAB) pri 460 nm. Titrimetri~na metoda je primerna za
obmo~je od 2,0–20,0 mg OXC. Obmo~je linearnosti je pri spektrofotometri~ni metodi med 0,3 in 6,0 μg mL–1 OXC s
korelacijskim koeficientom (r) 0,9967 (n = 6). Po IHC metodologiji sta bili izra~unani meji zaznave in kvantifikacije.
Metoda je bila uspe{no uporabljena za dolo~evanje OFX v tabletah.
